, and re-modelling extracellular matrix (ECM) [5]. In the infarcted mouse heart, therapeutic effects Commentary
The earlier hypothesis of cell-based therapy for heart disease has now become the mainstream of experimental and clinic concept albeit underlying mecha [11] . Well-documented cardiac protective actions of relaxin include anti-fibrosis [12, 13] , anti-oxidative stress [14] , antiapoptosis [14, 15] [14] . Pro-angiogenic action of relaxin has only been reported in skin wound, cancer or reproductive tissues [11, 17, 18] [11] . In settings of heart disease and cell therapy, combination of these actions would certainly be desirable (Fig. 1) . Interestingly, all these known actions of relaxin have been observed in the porcine infarcted cardiac tissue [9] . It is known that regional formation of a number of cytokines, chemokines, growth factors and MMPs are critical for stem cell homing, migration, myocyte-lineage formation and proliferation [19] . In addition, studies in noncardiac tissues have revealed that relaxin is able to synergistically activate the insulin-like growth factor (IGF1) signalling [21] . While [22] . Furthermore, cell coupling might also be improved in the presence of relaxin indicated by an earlier report from the same group that relaxin improves coupling of C2C12 myoblasts with neonate cardiomyocytes in co-culture by upregulating connexin-40 [23] (Fig. 1) . Thus, the findings from this study points to the option of giving complementary treatment with relaxin or relaxin gene either to "pre-conditioning" the diseased myocardium for subsequent cell implantation or in conjunction with cell delivery. In this regard, the optimal timing of pre-treatment followed by cell implantation will need to be carefully determined to maximize the efficacy.
. The anti-fibrotic effect of relaxin is attributable to its multiple actions by which it inhibits activation and proliferation of fibroblasts and promotes collagen degradation by up-regulating expression of MMPs together with down-regulation of certain subtypes of tissue inhibitors of metalloproteinases (TIMPs)
Collectively, these intriguing findings by Formigli et al. [9] 
